GTBP

GT Biopharma, Inc. GTBP

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GTBP ADIL BNTC CING CLSD LBUY LIXT PBLA TCON
6M -69.62 % -48.83 % 10.09 % -4.16 % -66.38 % 11.11 % 258.87 % -96.49 % 0.00 %
YTD -75.51 % -64.77 % 24.67 % -18.63 % -71.07 % 0.00 % 100.45 % -97.56 % 0.00 %
1Y -63.82 % -60.69 % 53.52 % -6.74 % -75.11 % -11.11 % 147.22 % -97.11 % -67.80 %
3Y -98.55 % -95.33 % 275.56 % -98.45 % -76.78 % -45.21 % -17.59 % -100.00 % -99.92 %
5Y -99.40 % -99.24 % -70.27 % -99.61 % -80.94 % -71.01 % -93.66 % -100.00 % -99.91 %
10Y -100.00 % -99.63 % -99.07 % -99.61 % -96.19 % -97.36 % -53.65 % -100.00 % -100.00 %
From the beginning -100.00 % -99.63 % -99.75 % -99.61 % -96.19 % -97.36 % -99.84 % -100.00 % -100.00 %

Dividend

Benitec Biopharma Inc.